Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis-Reference-Cited by-同舟云学术

Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis

Published:1999-09 Issue:3 Volume:31 Page:482-488
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Lin Han-Chieh,Huang Yi-Tsau,Wu Hann-Lung,Lee Wui-Chiang,Hou Ming-Chih,Lee Fa-Yauh,Chang Full-Young,Lee Shou-Dong

Publisher

Elsevier BV

Subject

Hepatology

Reference43 articles.

1. Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension;Vorobioff;Am J Physiol,1983

2. Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding;Lebrec;Pharmacol Ther,1994

3. Somatostatin in portal hypertension;Morgan;Dig Dis Sci,1989

4. The treatment of portal hypertension: a meta-analytic review;D'Amico;Hepatology,1995

5. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action;Bauer;Life Sci,1982

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation, Characterization and Related in Vivo Release, Safety and Toxicity Studies of Long Acting Lanreotide Microspheres;Biological and Pharmaceutical Bulletin;2012

2. Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats;Liver International;2011-10-03

3. The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension;Journal of Hepatology;2011-06

4. Inhibition of hepatic tumour necrosis factor-α attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers;Liver International;2009-05

5. Thalidomide decreases intrahepatic resistance in cirrhotic rats;Biochemical and Biophysical Research Communications;2009-03